Immuneering (IMRX) Retained Earnings: 2020-2024
Historic Retained Earnings for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to -$206.2 million.
- Immuneering's Retained Earnings fell 39.19% to -$206.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$206.2 million, marking a year-over-year decrease of 39.19%. This contributed to the annual value of -$163.3 million for FY2023, which is 48.70% down from last year.
- Per Immuneering's latest filing, its Retained Earnings stood at -$206.2 million for Q3 2024, which was down 7.62% from -$191.6 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Retained Earnings registered a high of -$25.7 million during Q4 2020, and its lowest value of -$206.2 million during Q3 2024.
- Moreover, its 3-year median value for Retained Earnings was -$135.6 million (2023), whereas its average is -$137.1 million.
- Data for Immuneering's Retained Earnings shows a maximum YoY slumped of 130.30% (in 2021) over the last 5 years.
- Over the past 5 years, Immuneering's Retained Earnings (Quarterly) stood at -$25.7 million in 2020, then slumped by 130.30% to -$59.3 million in 2021, then tumbled by 85.22% to -$109.8 million in 2022, then plummeted by 48.70% to -$163.3 million in 2023, then tumbled by 39.19% to -$206.2 million in 2024.
- Its Retained Earnings was -$206.2 million in Q3 2024, compared to -$191.6 million in Q2 2024 and -$177.6 million in Q1 2024.